Tübingen, Germany

Francois Paquet-Durand

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Graybug Vision, Inc., Mireca Medicines Gmbh. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francois Paquet-Durand. Retrieved from https://idiyas.com/inventor/francois-paquet-durand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Francois Paquet-Durand

Introduction

Francois Paquet-Durand is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of novel compounds that impact cellular signaling pathways.

Latest Patents

Paquet-Durand holds a patent for "Equatorially modified polymer linked multimers of guanosine-3', 5'-cyclic monophosphates." This invention focuses on new equatorially modified polymer linked multimers of guanosine-3', 5'-cyclic monophosphate (cGMP) analogues that inhibit the cGMP-signaling system. The patent also covers related monomeric compounds that may serve as precursors for the multimers and exhibit inhibitory activity. These compounds have potential applications in signal transduction research, modulation of cyclic nucleotide-regulated binding proteins, and various diagnostic applications.

Career Highlights

Francois Paquet-Durand is currently associated with Graybug Vision, Inc., where he continues to innovate in the field of biochemistry. His work has garnered attention for its potential applications in medical research and therapeutic development.

Collaborations

He has collaborated with notable colleagues such as Hans-Gottfried Genieser and Frank Schwede, contributing to advancements in their shared field of expertise.

Conclusion

Francois Paquet-Durand's innovative work in the development of cGMP analogues showcases his commitment to advancing biochemistry and its applications. His contributions are poised to have a lasting impact on research and therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…